EUVIMEDEUVIMED entdecken
Open Access

Transfer RNA derived fragment, tRF-Glu-CTC, aggravates the development of neovascular age-related macular degeneration

Yu Liang, Lingjie Kong, Yuelu Zhang, Yihan Zhang, Mingsu Shi, Jiaqiu Huang, Hongyu Kong, Siyi Qi, Yunlong Yang, Jiaxu Hong, Meidong Zhu, Xiangjia Zhu und 4 weitere

Theranostics · 2024

DOI: 10.7150/thno.92943 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Yu Liang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, 83 Fenyang Road, Shanghai, 200031, China. Hauptthemen laut MEDLINE: Wet Macular Degeneration, Choroidal Neovascularization. Die Arbeit wurde bisher 22-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Angiogenesis expedites tissue impairment in many diseases, including age-related macular degeneration (AMD), a leading cause of irreversible blindness in elderly. A substantial proportion of neovascular AMD patients, characterized by aberrant choroidal neovascularization (CNV), exhibit poor responses or adverse reactions to anti-VEGF therapy. Herein, we aimed to unveil the function of newly identified transfer RNA-derived small RNA, tRF-Glu-CTC, in the pathology of CNV and determine its potential in inhibiting angiogenesis.

Methods

Small non-coding RNA sequencing and quantitative polymerase chain reaction were conducted to detect expression pattern of tRF-Glu-CTC in CNV development. Immunofluorescence staining, fundus fluorescein angiography and ex vivo choroidal sprouting assays were employed for the evaluation of tRF-Glu-CTC's function in CNV development. The role of tRF-Glu-CTC in endothelial cells were determined by in vitro endothelial cell proliferation, migration and tube formation assays. Transcriptome sequencing, dual-luciferase reporter assay and in vitro experiments were conducted to investigate downstream mechanism of tRF-Glu-CTC mediated pathology. Results: tRF-Glu-CTC exhibited substantial up-regulation in AMD patients, laser-induced CNV model, and endothelial cells under hypoxia condition, which is a hallmark of CNV. Inhibiting tRF-Glu-CTC reduced angiogenesis and hypoxia stress in the neovascular region without neuroretina toxicity in laser-induced CNV model, showing an anti-angiogenic effect comparable to bevacizumab, while overexpression of tRF-Glu-CTC significantly augmented CNV. Mechanically, under hypoxia condition, angiogenin was involved in the production of tRF-Glu-CTC, which in turn triggered endothelial cell tubulogenesis, migration and promoted the secretion of inflammatory factors via the suppression of vasohibin 1 (VASH1). When downregulating VASH1 expression, the inhibition of tRF-Glu-CTC showed minimal suppression on angiogenesis.

Conclusions

This study demonstrated the important role of tRF-Glu-CTC in the progression of angiogenesis. Targeting of tRF-Glu-CTC may be an alternative to current anti-VEGF therapy for CNV in AMD and other conditions with angiogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wet Macular DegenerationChoroidal NeovascularizationHumansAgedAngiogenesis InhibitorsEndothelial CellsVascular Endothelial Growth Factor AVisual AcuityHypoxiaCell Cycle Proteins

Stichwörter der Autor:innen

Age-related macular degenerationangiogenesischoroidal neovascularizationtRNA-derived small noncoding RNAs

Substanzen

Angiogenesis InhibitorsVascular Endothelial Growth Factor AVASH1 protein, humanCell Cycle Proteins

Autor:innen und Institutionen

  • Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, 83 Fenyang Road, Shanghai, 200031, China.
  • NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, 83 Fenyang Road, Shanghai, 200031, China.
  • Shanghai Key Laboratory of Visual Impairment and Restoration, 83 Fenyang Road, Shanghai, 200031, China.
  • Department of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.
  • Save Sight Institute, Discipline of Clinical Ophthalmology and Eye Health, University of Sydney, Camperdown, NSW 2000, Australia.
  • New South Weals Tissue Bank, New South Weals Organ and Tissue Donation Service, Sydney Eye Hospital, 8 Macquarie Street, Sydney 2000, Australia.

Zitieren

APA

Liang, Y., Kong, L., Zhang, Y., Zhang, Y., Shi, M., Huang, J., Kong, H., Qi, S., Yang, Y., Hong, J., Zhu, M., Zhu, X., Sun, X., Zhang, S., Wu, L., & Zhao, C. (2024). Transfer RNA derived fragment, tRF-Glu-CTC, aggravates the development of neovascular age-related macular degeneration. Theranostics. https://doi.org/10.7150/thno.92943

Vancouver

Liang Y, Kong L, Zhang Y, Zhang Y, Shi M, Huang J, et al. Transfer RNA derived fragment, tRF-Glu-CTC, aggravates the development of neovascular age-related macular degeneration. Theranostics. 2024. doi:10.7150/thno.92943

BibTeX
@article{Liang2024,
  author = {Liang, Yu and Kong, Lingjie and Zhang, Yuelu and Zhang, Yihan and Shi, Mingsu and Huang, Jiaqiu and Kong, Hongyu and Qi, Siyi and Yang, Yunlong and Hong, Jiaxu and Zhu, Meidong and Zhu, Xiangjia and Sun, Xinghuai and Zhang, Shujie and Wu, Lianqun and Zhao, Chen},
  title = {Transfer RNA derived fragment, tRF-Glu-CTC, aggravates the development of neovascular age-related macular degeneration},
  journal = {Theranostics},
  year = {2024},
  doi = {10.7150/thno.92943}
}
Kostenlos starten →